Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19)

Summary

Introduction: Coronavirus disease 2019 (COVID-19) is a new pathology, declared a public health emergency by the World Health Organization, which can have negative consequences for pregnant women and their newborns. It is estimated that 1 in 5 women will develop a mental illness in the perinatal period. COVID-19 pandemic has been associated with anxiety and depression in the population. The current pandemic is a unique stressor with potentially wide-ranging consequences in the perinatal period, but little is known about the impact of COVID-19 on perinatal mental health. Thus, the objective of this study is to explore the experiences of pregnant and new mothers during the current pandemic, particularly its impact on perinatal mental health (including depression, anxiety, PTSD and psychological distress). Methods: The study design is a prospective observational study, with a baseline assessment and three follow-ups: one month; three months; and six months post baseline. This international study will be carried out in 11 European countries (Albania, Bulgaria, Cyprus, France, Greece, Israel, Malta, Portugal, Spain, Turkey, United Kingdom) Chile and Brazil. The study population will comprise pregnant women and new mothers with an infant under six months of age, covering a broad range of women across the perinatal period. Ethics and dissemination: The study and handling of the data will follow all national required data protection standards. Each researcher (or team of researchers) involved will submit the project to their local ethical committee before starting the project. Results from the project will be disseminated in peer reviewed journals and international conferences.

Conditions

• Post Traumatic Stress Disorder
• Depression
• Anxiety
• Psychological Distress

Sponsors & Collaborators

• Universidad Loyola Andalucia

  collaborator OTHER

• Beder College University. Albania

  collaborator UNKNOWN

• Mackenzie Presbiterian University, São Paulo, Brazil

  collaborator OTHER

• Medical University of Sofia

  collaborator OTHER

• European University Cyprus

  collaborator OTHER

• Groupe Hospitalier du Havre

  collaborator OTHER

• University of Athens

  collaborator OTHER

• Bar-Ilan University, Israel

  collaborator OTHER

• University of Malta

  collaborator OTHER

• Mount Carmel Health System

  collaborator OTHER

• University of Coimbra

  collaborator OTHER

• Universidade Católica Portuguesa

  collaborator OTHER

• Instituto de Saude Publica da Universidade do Porto

  collaborator OTHER

• University of Huelva

  collaborator OTHER

• Instituto de Investigação Biomédica de Malaga. Spain

  collaborator UNKNOWN

• Universidad Nacional de Educación a Distancia

  collaborator OTHER

• Kırklareli University

  collaborator OTHER

• King's College London

  collaborator OTHER

• Universidad de Concepcion

  collaborator OTHER

• University of Minho

  lead OTHER

Principal Investigators

• Ana Mesquita, PhD · University of Minho

• Emma Motrico, PhD · Universidad Loyola Andalucia

Eligibility

Min Age

18 Years

Sex

FEMALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2020-06-15

Primary Completion

2020-11-01

Completion

2021-02-28

Countries

• Albania
• Brazil
• Bulgaria
• Chile
• Cyprus
• France
• Greece
• Israel
• Malta
• Portugal
• Spain
• Turkey (Türkiye)
• United Kingdom

Study Locations